Atea Pharmaceuticals, Inc.
AVIR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001593899
No open-market purchases or sales by Atea Pharmaceuticals, Inc. insiders were filed in the last 90 days; 124 institutions reported holding it in 13F filings for Q2 2026, worth $276.4M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Atea Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 107
- −1 vs. Q3 2024
- Shares held
- 56.3M
- −1.58M (−2.7%) vs. Q3 2024
- Total value
- $188.7M
- −$5.35M (−2.8%) vs. Q3 2024
- New holders
- 15
- 38 more added
- Sold out
- 16
- 32 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AVIR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 124 | $276.4M |
| Q1 2026 | 127 | $322.8M |
| Q4 2025 | 111 | $203.5M |
| Q3 2025 | 115 | $154.2M |
| Q2 2025 | 107 | $189.7M |
| Q1 2025 | 104 | $158.3M |
| Q4 2024 | 107 | $188.7M |
| Q3 2024 | 108 | $194.0M |
| Q2 2024 | 105 | $187.7M |
| Q1 2024 | 113 | $219.6M |
| Q4 2023 | 108 | $168.3M |
| Q3 2023 | 119 | $170.6M |
| Q2 2023 | 133 | $213.3M |
| Q1 2023 | 131 | $190.2M |
| Q4 2022 | 131 | $278.1M |
| Q3 2022 | 126 | $326.8M |
| Q2 2022 | 128 | $408.7M |
| Q1 2022 | 127 | $396.6M |
| Q4 2021 | 143 | $479.2M |
| Q3 2021 | 142 | $1.99B |
| Q2 2021 | 104 | $1.27B |
| Q1 2021 | 82 | $3.20B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Atea Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $8.33M | 0.98% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 3,341,653 | $11.2M | 0.45% | −2,100,243−38.6% | Reduced |
| Vanguard Group Inc | 4,666,854 | $15.6M | 0.00% | −184,364−3.8% | Reduced |
| Tang Capital Management LLC | 4,788,912 | $16.0M | 1.06% | +181,852+3.9% | Added |
| FMR LLC | 6,425,225 | $21.5M | 0.00% | −193,072−2.9% | Reduced |
| BML Capital Management, LLC | 7,608,312 | $25.5M | 15.83% | +958,312+14.4% | Added |
| BlackRock, Inc. | 9,062,181 | $30.4M | 0.00% | +71,447+0.8% | Added |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −323,542−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −103,358−100.0% | Sold out |
| Alps Advisors Inc | 0 | $0 | 0.00% | −64,692−100.0% | Sold out |
| Berkshire Asset Management LLC | 0 | $0 | 0.00% | −65,000−100.0% | Sold out |
| Deutsche Bank AG | 0 | $0 | 0.00% | −49,567−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −38,515−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −29,491−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −13,964−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −13,868−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −13,143−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −11,178−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −10,912−100.0% | Sold out |
| Gladius Capital Management LP | 0 | $0 | 0.00% | −8,491−100.0% | Sold out |
| Global Retirement Partners, LLC | 0 | $0 | 0.00% | −1,389−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −69−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −31−100.0% | Sold out |